These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23242192)

  • 41. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.
    Theuns DAMJ; Brouwer TF; Jones PW; Allavatam V; Donnelley S; Auricchio A; Knops RE; Burke MC
    Heart Rhythm; 2018 Oct; 15(10):1515-1522. PubMed ID: 29758404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE.
    Zeitler EP; Friedman DJ; Loring Z; Campbell KB; Goldstein SA; Wegermann ZK; Schutz J; Smith N; Black-Maier E; Al-Khatib SM; Piccini JP
    Heart Rhythm; 2020 Mar; 17(3):447-454. PubMed ID: 31561032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subcutaneous or Transvenous Defibrillator Therapy.
    Knops RE; Olde Nordkamp LRA; Delnoy PHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; van der Stuijt W; de Weger A; de Wilde KC; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Tijssen JGP; Wilde AAM;
    N Engl J Med; 2020 Aug; 383(6):526-536. PubMed ID: 32757521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
    Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
    Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    J Am Coll Cardiol; 1999 Nov; 34(5):1552-9. PubMed ID: 10551706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial.
    Al-Khatib SM; Piccini JP; Knight D; Stewart M; Clapp-Channing N; Sanders GD
    J Cardiovasc Electrophysiol; 2010 May; 21(5):545-50. PubMed ID: 20021522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
    Landolina M; Perego GB; Lunati M; Curnis A; Guenzati G; Vicentini A; Parati G; Borghi G; Zanaboni P; Valsecchi S; Marzegalli M
    Circulation; 2012 Jun; 125(24):2985-92. PubMed ID: 22626743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Manpower and outpatient clinic workload for remote monitoring of patients with cardiac implantable electronic devices: data from the HomeGuide Registry.
    Ricci RP; Morichelli L; D'Onofrio A; Calò L; Vaccari D; Zanotto G; Curnis A; Buja G; Rovai N; Gargaro A
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1216-23. PubMed ID: 24964380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality.
    Proietti R; Labos C; Davis M; Thanassoulis G; Santangeli P; Russo V; Di Biase L; Roux JF; Verma A; Natale A; Essebag V
    Can J Cardiol; 2015 Mar; 31(3):270-7. PubMed ID: 25746019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Technical and practical aspects of remote monitoring of implantable cardioverter-defibrillator patients in Poland - preliminary results.
    Przybylski A; Zakrzewska-Koperska J; Maciag A; Derejko P; Orczykowski M; Szumowski L; Walczak F
    Kardiol Pol; 2009 May; 67(5):505-11. PubMed ID: 19521935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial.
    Versteeg H; Timmermans I; Widdershoven J; Kimman GJ; Prevot S; Rauwolf T; Scholten MF; Zitron E; Mabo P; Denollet J; Pedersen SS; Meine M
    Europace; 2019 Sep; 21(9):1360-1368. PubMed ID: 31168604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rationale and design of the MONITOR-ICD study: a randomized comparison of economic and clinical effects of automatic remote MONITORing versus control in patients with Implantable Cardioverter Defibrillators.
    Zabel M; Müller-Riemenschneider F; Geller JC; Brachmann J; Kühlkamp V; Dissmann R; Reinhold T; Roll S; Lüthje L; Bode F; Eckardt L; Willich SN;
    Am Heart J; 2014 Oct; 168(4):430-7. PubMed ID: 25262251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique.
    Migliore F; Mattesi G; De Franceschi P; Allocca G; Crosato M; Calzolari V; Fantinel M; Ortis B; Facchin D; Daleffe E; Fabris T; Marras E; De Lazzari M; Zanon F; Marcantoni L; Siciliano M; Corrado D; Iliceto S; Bertaglia E; Zecchin M
    J Cardiovasc Electrophysiol; 2019 Jun; 30(6):854-864. PubMed ID: 30827041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study.
    El-Chami MF; Burke MC; Herre JM; Shah MH; Sadhu A; Niebauer MJ; Kutalek SP; Carter N; Gold MR
    Heart Rhythm; 2020 Sep; 17(9):1566-1574. PubMed ID: 32376304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rationale and design of the health economics evaluation registry for remote follow-up: TARIFF.
    Ricci RP; D'Onofrio A; Padeletti L; Sagone A; Vicentini A; Vincenti A; Morichelli L; Cavallaro C; Ricciardi G; Lombardi L; Fusco A; Rovaris G; Silvestri P; Guidotto T; Pollastrelli A; Santini M
    Europace; 2012 Nov; 14(11):1661-5. PubMed ID: 22544910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic impact of inappropriate defibrillator shocks in a population cohort.
    Deyell MW; Qi A; Chakrabarti S; Yeung-Lai-Wah JA; Tung S; Khoo C; Bennett MT; Qian H; Kerr CR
    Heart; 2013 Sep; 99(17):1250-5. PubMed ID: 23468515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of remote monitoring on reducing the burden of inappropriate shocks related to implantable cardioverter-defibrillator lead fractures: insights from a French single-centre registry.
    Souissi Z; Guédon-Moreau L; Boulé S; Kouakam C; Finat L; Marquié C; Brigadeau F; Wissocque L; Mouton S; Montaigne D; Klug D; Kacet S; Lacroix D
    Europace; 2016 Jun; 18(6):820-7. PubMed ID: 26498163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.